New NHS data reveals ovarian cancer injustices
A reminder why we fight: latest ovarian cancer data from NHS Digital reveals injustices that disproportionately affect those who die from ovarian cancer.
News
Read our latest updates from research breakthroughs to government actions to fundraising heroes.
Future is certain for niraparib in recurrent ovarian cancer
Announcement that niraparib from second line of treatment for recurrent ovarian cancer will be available long term on the NHS in England and Wales.
Do enough of us know the symptoms? We investigate
New data reveals how aware the UK is of ovarian cancer and its symptoms.
Taking action on long waiting times
Our new report confirms ovarian cancer has the second longest treatment wait times of all cancers.
New World Ovarian Cancer Coalition Chair announced
Annwen Jones OBE, Chief Executive of Target Ovarian Cancer, becomes Chair of the World Ovarian Cancer Coalition.
Moving Forwards Together
Our first ever digital conference Moving Forwards Together was just the beginning...
Pioneering drug combination made available UK-wide
New combination of olaparib and bevacizumab means a leap forward in personalised treatments.
News on access to niraparib from second line of treatment
Initial decision announced to make niraparib available from second line of treatment only to people with a BRCA1 or BRCA2 mutation.
Claudia Winkleman presents our BBC Lifeline Appeal
Your donations will be matched pound for pound, up to £30,000!
Breaking down barriers to early diagnosis
We’re ending the postcode lottery in early diagnosis of ovarian cancer.
NHSE ovarian cancer audit announced
We welcome NHS England's landmark announcement to fund an ovarian cancer audit.
Volunteers' Week 2021: a big thank you!
Our volunteers have been spreading the word, sharing stories and campaigning to raise awareness for Target Ovarian Cancer.
